1.Predictive and Prognostic Factors of Viral Encephalitis in Pediatric Patients.
Jaeyeon KIM ; Yu Gene PARK ; Jiwon LEE ; Ji Hye KIM ; Munhyang LEE ; Jeehun LEE
Journal of the Korean Child Neurology Society 2017;25(2):99-105
PURPOSE: Encephalitis is an inflammation affecting brain parenchyma. At the time of presentation, it may be difficult to differentiate between viral encephalitis and altered mental status or seizures during febrile illness. The aim of the present study is to identify the predictive factors and to determine the prognostic factors of viral encephalitis in children presenting as seizure with fever. METHODS: From the retrospective review of the medical records, children with seizures or altered mental status during febrile illness who presented to Samsung Medical Center between January 2008 and May 2013 were included in the study. RESULTS: 81 patients were enrolled in this study (female:male=32:49). The mean age at admission was 4.9±4.3 years (range 0–14 years old). The patients were categorized into two groups according to the clinical diagnosis: (1) Viral encephalitis (VIRAL ENC, n=66), (2) Complex febrile seizures imitating viral encephalitis(C-FS, n=15). The predictive factors of viral encephalitis were focal and/or lateralized abnormalities in electroencephalography (EEG) (P<0.001). CONCLUSION: EEG can be helpful to predict the viral encephalitis, in pediatric patient who shows delayed restoration of consciousness after seizure during febrile illness.
Brain
;
Child
;
Consciousness
;
Diagnosis
;
Electroencephalography
;
Encephalitis
;
Encephalitis, Viral*
;
Fever
;
Humans
;
Inflammation
;
Medical Records
;
Retrospective Studies
;
Seizures
;
Seizures, Febrile
2.Desensitization to Oxcarbazepine: Long-Term Efficacy and Tolerability.
Jiwon LEE ; Eu Gene PARK ; Munhyang LEE ; Jeehun LEE
Journal of Clinical Neurology 2017;13(1):47-54
BACKGROUND AND PURPOSE: Antiepileptic drug (AED)-associated cutaneous adverse drug reactions can lead to the discontinuation of medications. The aim of this study was to determine the long-term efficacy and safety of performing desensitization to oxcarbazepine. METHODS: This study involved 20 patients who exhibited cutaneous adverse drug reactions associated with oxcarbazepine use between July 2009 and March 2016 at Samsung Medical Center. All of the participants had to discontinue oxcarbazepine despite presenting initially positive responses. Human leukocyte antigen genotyping was performed to detect the genetic predisposition to Stevens-Johnson syndrome. The desensitization to oxcarbazepine was performed with a starting dosage of 0.1 mg/day. Efficacy was evaluated by comparing the frequency of seizures before and at 1 and 3 years after desensitization. Adverse events occurring during desensitization and the retention rate after desensitization were also investigated. RESULTS: Nineteen patients (95%) safely completed the desensitization protocol. One withdrew owing to emotional problems that appeared to be associated with oxcarbazepine. The follow-up period was 4.6±1.2 years (mean±SD), and oxcarbazepine was maintained for more than 3 years after desensitization in 15 patients (83.3%). The response rates were 84.2% and 77.8% at 1 and 3 years after desensitization, respectively. Eight patients remained seizure-free for 3 years, and two discontinued all AEDs. Transient adverse reactions such as mild rash and itching were reported by five patients during desensitization. CONCLUSIONS: This study has demonstrated the long-term efficacy and safety of desensitization to oxcarbazepine in patients exhibiting cutaneous adverse drug reactions. This favorable outcome should encourage the implementation of desensitization in patients presenting with hypersensitivity to oxcarbazepine as an alternative strategy in clinical practice.
Drug Resistant Epilepsy
;
Drug-Related Side Effects and Adverse Reactions
;
Exanthema
;
Follow-Up Studies
;
Genetic Predisposition to Disease
;
Humans
;
Hypersensitivity
;
Leukocytes
;
Pruritus
;
Seizures
;
Stevens-Johnson Syndrome
3.A case of FLNA gene mutation with respiratory insufficiency and periventricular heterotopia
Hwanhee PARK ; Min Seung PARK ; Chang Seok KI ; Joongbum CHO ; Jeehun LEE ; Jihyun KIM ; Kangmo AHN
Allergy, Asthma & Respiratory Disease 2019;7(3):158-164
Filamin A is an actin-binding protein and, in humans, is encoded by FLNA gene in the long arm of X chromosome. Filamin A plays a role in the formation of cytoskeleton by crosslinking actin filaments in cytoplasm. FLNA mutations affect cytoskeletal regulatory processes and cellular migrating abnormalities that result in periventricular heterotopia. A 5-month-old girl was hospitalized because of breathing difficulty and was diagnosed as having periventricular heterotopia with laryngomalacia, cricopharyngeal incoordination, pulmonary hypertension, and chronic lung disease. A genetic test was performed to find the cause of periventricular heterotopia, and FLNA gene mutation (c.5998+1G>A) was confirmed for the first time in Korea. After discharge, she developed respiratory failure due to a viral infection at 8 months of her age. In spite of management with mechanical ventilation, she died of pneumothorax and pulmonary hemorrhage. Herein, we report a case of FLNA gene mutation who presented with periventricular nodular heterotopia with respiratory insufficiency.
Actin Cytoskeleton
;
Arm
;
Ataxia
;
Cytoplasm
;
Cytoskeleton
;
Female
;
Filamins
;
Hemorrhage
;
Humans
;
Hypertension, Pulmonary
;
Infant
;
Korea
;
Laryngomalacia
;
Lung Diseases
;
Periventricular Nodular Heterotopia
;
Pneumothorax
;
Respiration
;
Respiration, Artificial
;
Respiratory Insufficiency
;
X Chromosome
4.Complications of the Central Nervous System in Pediatric Patients With Common Cold Coronavirus Infection During 2014–2019
Hwanhee PARK ; Kyung-Ran KIM ; Hee Jae HUH ; Yoonsun YOON ; Esther PARK ; Joongbum CHO ; Jiwon LEE ; Jeehun LEE ; Ji Hye KIM ; Yae-Jean KIM
Journal of Korean Medical Science 2023;38(46):e358-
Background:
In pediatric patients, the common cold coronavirus (ccCoV) usually causes mild respiratory illness. There are reports of coronavirus causing central nervous system (CNS) infection in experimental animal models. Some immunocompromised patients have also been reported to have fatal CNS infections with ccCoV. The aim of this study was to investigate the clinical characteristics of CNS complications related to ccCoV infection.
Methods:
From January 2014 to December 2019, a retrospective analysis was performed of medical records from hospitalized patients under 19 years of age whose ccCoV was detected through polymerase chain reaction in respiratory specimens. The CNS complications were defined as clinically diagnosed seizure, meningitis, encephalopathy, and encephalitis.
Results:
A total of 436 samples from 420 patients were detected as ccCoV. Among the 420 patients, 269 patients were immunocompetent and 151 patients were immunocompromised.The most common type of ccCoV was OC43 (52% in immunocompetent, 37% in immunocompromised). CNS complications were observed in 9.4% (41/436). The most common type of CNS complication was the fever-provoked seizure under pre-existing neurologic disease (42% in immunocompetent and 60% in immunocompromised patients).Among patients with CNS complications, two immunocompetent patients required intensive care unit admission due to encephalitis. Three patients without underlying neurological disease started anti-seizure medications for the first time at this admission. There was no death related to ccCoV infection.
Conclusion
ccCoV infection may cause severe clinical manifestations such as CNS complications or neurologic sequelae, even in previously healthy children.
5.A Korean Patient with Early Juvenile Form of Metachromatic Leukodystrophy: Biochemical and Molecular Genetic Investigation.
Yeong Bin KIM ; Hyung Doo PARK ; Rihwa CHOI ; Soo Youn LEE ; Chang Seok KI ; Junghan SONG ; Jong Won KIM ; Jeehun LEE
Laboratory Medicine Online 2017;7(1):41-44
Metachromatic leukodystrophy is an inherited lysosomal storage disorder caused by the deficiency of arylsulfatase A activity. The patient in this study, a 5-yr-old girl, presented with progressive psychomotor regression. An MRI image of her brain showed bilateral symmetrical demyelination. The arylsulfatase A activity in her leukocytes was decreased to 8.0 nmol/hr/mg protein (reference range, 25-80 nmol/hr/mg protein). Mutation analysis of ARSA, using PCR and direct sequencing, showed two heterozygote pathogenic variations of c.449C>T (p.Pro150Leu) and c.640G>A (p.Ala214Thr). In summary, we report a Korean patient with an early juvenile form of metachromatic leukodystrophy, who was diagnosed based on her clinical symptoms as well as by using biochemical, radiological, and molecular genetic investigations.
Brain
;
Cerebroside-Sulfatase
;
Demyelinating Diseases
;
Female
;
Heterozygote
;
Humans
;
Leukocytes
;
Leukodystrophy, Metachromatic*
;
Magnetic Resonance Imaging
;
Molecular Biology*
;
Polymerase Chain Reaction
6.Altered Gene Expression Profiles in Neural Stem Cells Derived from Duchenne Muscular Dystrophy Patients with Intellectual Disability
Jahong KOO ; Subin PARK ; Soo-Eun SUNG ; Jeehun LEE ; Dae Soo KIM ; Jungwoon LEE ; Jae-Ran LEE ; Nam-Soon KIM ; Da Yong LEE
Experimental Neurobiology 2021;30(4):263-274
Intellectual disability (ID) is a neurodevelopmental disorder defined by below-average intelligence (intelligence quotient of <70) accompanied by adaptive behavior deficits. Defects in the functions of neural stem cells during brain development are closely linked to the pathogenesis of ID. To understand the molecular etiology of ID, we examined neural stem cells from individuals with Duchenne muscular dystrophy (DMD), a genetic disorder in which approximately one-third of the patients exhibit ID. In this study, we generated induced pluripotent stem cells from peripheral blood mononuclear cells from a normal individual and DMD patients with and without ID to identify ID-specific functional and molecular abnormalities. We found defects in neural ectoderm formation in the group of DMD patients with ID. Our transcriptome analysis of patient-derived neural stem cells revealed altered expression of genes related to the hippo signaling pathway and neuroactive ligand-receptor interaction, implicating these in the pathogenesis of ID in patients with DMD.
7.Altered Gene Expression Profiles in Neural Stem Cells Derived from Duchenne Muscular Dystrophy Patients with Intellectual Disability
Jahong KOO ; Subin PARK ; Soo-Eun SUNG ; Jeehun LEE ; Dae Soo KIM ; Jungwoon LEE ; Jae-Ran LEE ; Nam-Soon KIM ; Da Yong LEE
Experimental Neurobiology 2021;30(4):263-274
Intellectual disability (ID) is a neurodevelopmental disorder defined by below-average intelligence (intelligence quotient of <70) accompanied by adaptive behavior deficits. Defects in the functions of neural stem cells during brain development are closely linked to the pathogenesis of ID. To understand the molecular etiology of ID, we examined neural stem cells from individuals with Duchenne muscular dystrophy (DMD), a genetic disorder in which approximately one-third of the patients exhibit ID. In this study, we generated induced pluripotent stem cells from peripheral blood mononuclear cells from a normal individual and DMD patients with and without ID to identify ID-specific functional and molecular abnormalities. We found defects in neural ectoderm formation in the group of DMD patients with ID. Our transcriptome analysis of patient-derived neural stem cells revealed altered expression of genes related to the hippo signaling pathway and neuroactive ligand-receptor interaction, implicating these in the pathogenesis of ID in patients with DMD.
8.Early Diagnosis of Perinatal Ischemic Stroke Based on Clinical and Radiological Characteristics.
Hee Su KIM ; Jeehun LEE ; Cha Gon LEE ; Sook Hyun NAM ; Hong EO ; Ji Hye KIM ; Yun Sil CHANG ; Won Soon PARK ; Munhyang LEE
Journal of the Korean Child Neurology Society 2011;19(2):131-141
PURPOSE: Perinatal ischemic stroke (PIS) has been increasingly recognized and regarded as one of the major causes of neurological disability occurring in the neonatal period. Due to its vague presenting symptoms, the clinical diagnosis of PIS can be delayed. The aim of this study was to delineate the clinical and radiological characteristics of PIS in order to establish its early diagnosis. METHODS: From January 2002 to October 2010, 24 neonates with evidence of ischemic cerebral infarction on brain magnetic resonance imaging (MRI) were enrolled. Perinatal and neonatal clinical characteristics, electroencephalogram (EEG), and brain MRI findings were retrospectively reviewed. Using those data, analysis was done to elicit clues for early diagnosis and prognostic factors of PIS. RESULTS: Sixteen males and eight females were diagnosed with PIS. Twelve cases presented with apnea and ten patients with seizures. The diagnosis of PIS was confirmed by brain MRI. Sixteen patients (66.7%) had infarction in the territory of the middle cerebral artery, and fifteen neonates had infarction in the left hemisphere. Of 11 infants who presented with a focal lesion on brain MRI, three patients were diagnosed by diffusion weighted images (DWI). Their T2- and FLAIR sequences showed subtle signal changes, whereas DWI revealed bright signal intensity. Thirteen patients were included in the delayed diagnostic group (diagnostic interval >24 hours). In those patients, apnea (69.2%) was more likely than seizures (15.4%) to be the initial symptom. The extent of the lesion on brain MRI was likely to be a better predictor of the neurologic outcome. Hemiplegia or hemiparesis was found in seven patients who had extensive lesions involving the gray and white matter, internal capsule, and basal ganglia. CONCLUSION: PIS should be considered as a differential diagnosis for neonates who present with apnea, lethargy or subtle seizures. DWI of brain MRI is very useful for early diagnosis of PIS. The extent of the lesion was also found to be significantly associated with poor outcome.
Apnea
;
Brain
;
Cerebral Infarction
;
Diagnosis, Differential
;
Diffusion
;
Early Diagnosis
;
Electroencephalography
;
European Continental Ancestry Group
;
Female
;
Hemiplegia
;
Humans
;
Infant
;
Infant, Newborn
;
Infarction
;
Internal Capsule
;
Lethargy
;
Magnetic Resonance Imaging
;
Male
;
Middle Cerebral Artery
;
Neurologic Manifestations
;
Paresis
;
Retrospective Studies
;
Seizures
;
Stroke
9.Development of exosome membrane materials-fused microbubbles for enhanced stability and efficient drug delivery of ultrasound contrast agent.
Yongho JANG ; Jeehun PARK ; Pilsu KIM ; Eun-Joo PARK ; Hyungjin SUN ; Yujin BAEK ; Jaehun JUNG ; Tai-Kyong SONG ; Junsang DOH ; Hyuncheol KIM
Acta Pharmaceutica Sinica B 2023;13(12):4983-4998
Lipid-coated microbubbles are widely used as an ultrasound contrast agent, as well as drug delivery carriers. However, the two main limitations in ultrasound diagnosis and drug delivery using microbubbles are the short half-life in the blood system, and the difficulty of surface modification of microbubbles for active targeting. The exosome, a type of extracellular vesicle, has a preferentially targeting ability for its original cell. In this study, exosome-fused microbubbles (Exo-MBs) were developed by embedding the exosome membrane proteins into microbubbles. As a result, the stability of Exo-MBs is improved over the conventional microbubbles. On the same principle that under the exposure of ultrasound, microbubbles are cavitated and self-assembled into nano-sized particles, and Exo-MBs are self-assembled into exosome membrane proteins-embedded nanoparticles (Exo-NPs). The Exo-NPs showed favorable targeting properties to their original cells. A photosensitizer, chlorin e6, was loaded into Exo-MBs to evaluate therapeutic efficacy as a drug carrier. Much higher therapeutic efficacy of photodynamic therapy was confirmed, followed by cancer immunotherapy from immunogenic cell death. We have therefore developed a novel ultrasound image-guided drug delivery platform that overcomes the shortcomings of the conventional ultrasound contrast agent and is capable of simultaneous photodynamic therapy and cancer immunotherapy.